Clinical Trials
3 trialsNCT04050462 2025-10-16
Nivolumab Combined With BMS-986253 in HCC Patients
NYU Langone Health
Phase 2 Terminated
NCT04347226 2025-05-22
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Columbia University
Phase 2 Terminated
NCT03689699 2025-04-29
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
Columbia University
Phase 1/2 Active not recruiting